OCX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 2.05%

Insider Buying (Last 12 Months): $2,694,851.24

Insider Selling (Last 12 Months): $0.00

OncoCyte Insider Trading History Chart

OncoCyte Share Price & Price History

^$3.18

▲ +0.445 (16.30%)

As of 06/17/2025 08:21 PM ET

OncoCyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/7/2025	Andrea S James	CFO	Buy	97,561	$2.05	$200,000.05	151,231
2/7/2025	Patrick W Smith	Major Shareholder	Buy	1,077,600	$2.05	$2,209,080.00	2,872,671
2/4/2025	Patrick W Smith	Major Shareholder	Buy	25	$2.02	$50.50	1,795,071
1/31/2025	Patrick W Smith	Major Shareholder	Buy	890	$2.01	$1,788.90	1,795,046
1/29/2025	Patrick W Smith	Major Shareholder	Buy	3,880	$2.01	$7,798.80	1,793,838
1/13/2025	Patrick W Smith	Major Shareholder	Buy	5,669	$2.08	$11,791.52	1,779,572
12/26/2024	Andrew Arno	Director	Buy	12,500	$2.11	$26,375.00	81,554
12/26/2024	Patrick W Smith	Major Shareholder	Buy	90,219	$2.13	$192,166.47	1,773,903
12/5/2024	Andrea S James	CFO	Buy	20,000	$2.29	$45,800.00	53,670
10/2/2024	Andrea S James	CFO	Buy	33,670	$2.97	$99,999.90	33,670
10/2/2024	Broadwood Partners, L.P.	Major Shareholder	Buy	1,315,339	$2.95	$3,880,250.05	6,244,405
4/11/2024	Andrew Arno	Director	Buy	33,898	$2.95	$99,999.10	69,054
4/11/2024	Broadwood Partners, L.P.	Major Shareholder	Buy	2,420,000	$2.92	$7,066,400.00	4,929,066
4/11/2024	Josh Riggs	CEO	Buy	3,390	$2.95	$10,000.50	3,505
6/14/2023	Alfred D Kingsley	Director	Buy	1,500	$4.20	$6,300.00	23,455
4/5/2023	Pura Vida Investments, Llc	Major Shareholder	Buy	33,150	$6.00	$198,900.00	404,510
4/3/2023	Broadwood Partners, L.P.	Major Shareholder	Buy	1,341,381	$6.00	$8,048,286.00	2,509,066
12/22/2022	Alfred D Kingsley	Director	Buy	1,250	$5.60	$7,000.00	21,955

SEC Filings (Institutional Ownership Changes) for OncoCyte (NASDAQ:OCX)

55.35% of OncoCyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

OncoCyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/25/2025	Defender Capital LLC.	32,928	$99K	0.0%	N/A	0.115%
5/16/2025	Broadwood Capital Inc.	11,410,100	$34.92M	2.8%	+82.7%	39.897%
5/16/2025	AWM Investment Company Inc.	2,822,530	$8.64M	1.2%	+263.8%	9.869%
5/13/2025	Wealthedge Investment Advisors LLC	73,971	$0.23M	0.1%	+40.3%	0.259%
4/17/2025	FNY Investment Advisers LLC	39,172	$0.12M	0.1%	-20.7%	0.137%
3/12/2025	Wealthedge Investment Advisors LLC	52,732	$0.13M	0.1%	N/A	0.302%
2/18/2025	AWM Investment Company Inc.	775,804	$1.85M	0.2%	-29.3%	4.610%
2/17/2025	Ground Swell Capital LLC	10,915	$26K	0.0%	N/A	0.063%
2/17/2025	Broadwood Capital Inc.	6,244,405	$14.86M	1.2%	+26.7%	37.103%
2/14/2025	Two Sigma Securities LLC	13,215	$31K	0.0%	N/A	0.079%
2/12/2025	Geode Capital Management LLC	137,069	$0.33M	0.0%	+31.8%	0.814%
2/12/2025	Pura Vida Investments LLC	654,451	$1.56M	4.9%	+32.1%	3.889%
1/13/2025	FNY Investment Advisers LLC	49,377	$0.12M	0.1%	+15.1%	0.293%
11/16/2024	Geode Capital Management LLC	103,980	$0.30M	0.0%	+12.2%	0.618%
2/13/2024	Pura Vida Investments LLC	586,930	$1.47M	0.4%	-10.8%	7.106%
1/23/2024	Defender Capital LLC.	71,650	$0.18M	0.1%	-37.4%	0.867%
11/14/2023	AWM Investment Company Inc.	719,282	$2.36M	0.3%	-94.9%	8.708%
10/23/2023	Defender Capital LLC.	114,520	$0.36M	0.1%	-95.1%	1.390%
8/14/2023	Pura Vida Investments LLC	13,625,022	$3.13M	0.4%	-3.8%	165.352%
8/11/2023	AWM Investment Company Inc.	14,185,664	$3.26M	0.4%	+109.4%	172.156%
4/27/2023	Defender Capital LLC.	2,363,430	$0.84M	0.3%	+4.0%	1.981%
2/14/2023	AWM Investment Company Inc.	7,254,222	$2.33M	0.3%	-6.4%	6.114%
1/24/2023	Penbrook Management LLC	207,675	$67K	0.1%	-63.1%	0.175%
1/12/2023	Defender Capital LLC.	2,272,930	$0.73M	0.3%	-10.9%	1.916%
11/14/2022	Ergoteles LLC	64,302	$47K	0.0%	-72.3%	0.054%
10/18/2022	Defender Capital LLC.	2,551,980	$1.88M	0.7%	-1.4%	2.152%
8/16/2022	Pura Vida Investments LLC	18,056,274	$16.25M	0.9%	+47.7%	15.236%
8/12/2022	AWM Investment Company Inc.	7,746,557	$6.97M	1.1%	+3,102.8%	6.536%
7/26/2022	Defender Capital LLC.	2,589,380	$2.33M	0.9%	+1.1%	2.185%
6/7/2022	Defender Capital LLC.	2,562,130	$4M	1.4%	+15.6%	2.564%
5/11/2022	GSA Capital Partners LLP	158,004	$0.24M	0.0%	-37.4%	0.171%
4/29/2022	Nisa Investment Advisors LLC	84,368	$0.13M	0.0%	-29.7%	0.091%
4/22/2022	Defender Capital LLC.	2,562,130	$4M	0.4%	+15.6%	2.777%
2/15/2022	Cinctive Capital Management LP	140,925	$0.31M	0.0%	-47.1%	0.153%
2/14/2022	GSA Capital Partners LLP	252,298	$0.55M	0.1%	N/A	0.274%
2/14/2022	Williams Jones Wealth Management LLC.	15,000	$33K	0.0%	N/A	0.016%
2/10/2022	Fort Sheridan Advisors LLC	135,000	$0.29M	0.1%	+22.7%	0.146%
2/9/2022	Wealth Effects LLC	43,500	$94K	0.0%	N/A	0.047%
2/8/2022	ProShare Advisors LLC	26,136	$56K	0.0%	N/A	0.028%
2/8/2022	Northern Trust Corp	582,542	$1.26M	0.0%	-2.1%	0.632%
2/1/2022	Defender Capital LLC.	2,216,800	$4.81M	1.5%	+13.1%	2.404%
1/28/2022	Allspring Global Investments Holdings LLC	26,869	$58K	0.0%	N/A	0.029%
1/20/2022	Caliber Wealth Management LLC	75,330	$0.14M	0.1%	+13.8%	0.082%
11/16/2021	Schonfeld Strategic Advisors LLC	1,270,967	$4.52M	0.0%	-8.5%	1.378%
11/16/2021	Squarepoint Ops LLC	79,429	$0.28M	0.0%	+14.9%	0.086%
11/16/2021	Two Sigma Advisers LP	740,700	$2.64M	0.0%	+12.0%	0.803%
11/16/2021	Two Sigma Investments LP	553,324	$1.97M	0.0%	+3.0%	0.600%
11/15/2021	Marshall Wace LLP	63,216	$0.23M	0.0%	-54.4%	0.069%
11/15/2021	Broadwood Capital Inc.	17,349,945	$61.77M	3.1%	+3.4%	18.811%
11/15/2021	Voya Investment Management LLC	26,708	$95K	0.0%	-11.7%	0.029%
11/15/2021	Polar Capital Holdings Plc	106,422	$0.38M	0.0%	+60.0%	0.115%
11/12/2021	The Manufacturers Life Insurance Company	19,842	$71K	0.0%	-54.1%	0.022%
11/12/2021	Geode Capital Management LLC	1,156,834	$4.12M	0.0%	-5.0%	1.263%
11/12/2021	B. Riley Wealth Management Inc.	14,000	$50K	0.0%	N/A	0.015%
11/10/2021	Goldman Sachs Group Inc.	417,515	$1.49M	0.0%	+8.8%	0.456%
11/9/2021	Barclays PLC	24,592	$87K	0.0%	+141.7%	0.027%
11/9/2021	BlackRock Inc.	4,368,736	$15.55M	0.0%	-7.6%	4.770%
11/9/2021	Principal Financial Group Inc.	10,674	$38K	0.0%	-92.1%	0.012%
11/8/2021	State Board of Administration of Florida Retirement System	22,947	$82K	0.0%	-72.7%	0.025%
11/4/2021	Deutsche Bank AG	50,808	$0.18M	0.0%	+11.2%	0.055%
11/2/2021	Raymond James Financial Services Advisors Inc.	15,749	$56K	0.0%	N/A	0.017%
11/2/2021	Cambridge Investment Research Advisors Inc.	40,600	$0.15M	0.0%	-12.9%	0.044%
11/2/2021	New York State Common Retirement Fund	36,212	$0.13M	0.0%	-25.6%	0.040%
11/1/2021	Defender Capital LLC.	1,960,820	$6.94M	2.3%	+45.5%	2.141%
11/1/2021	SG Americas Securities LLC	24,478	$87K	0.0%	N/A	0.027%
10/26/2021	Penbrook Management LLC	577,200	$2.06M	1.3%	+36.9%	0.630%
10/25/2021	Colonial River Wealth Management LLC	66,200	$0.22M	0.2%	N/A	0.072%
10/22/2021	Strs Ohio	50,300	$0.18M	0.0%	+106.1%	0.055%
9/3/2021	Parametric Portfolio Associates LLC	32,768	$0.19M	0.0%	+91.3%	0.036%

Data available starting January 2016

OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Today's Range

Now: $3.18

$2.71

$3.21

50 Day Range

MA: $3.07

$2.60

$3.44

52 Week Range

Now: $3.18

$1.92

$4.75

Volume

100,514 shs

Average Volume

58,260 shs

Market Capitalization

$90.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97

Who are the company insiders with the largest holdings of OncoCyte?: OncoCyte's top insider investors include:
Broadwood Partners, LP (Major Shareholder)
Patrick W Smith (Major Shareholder)
Andrea S James (CFO)
Andrew Arno (Director)
Josh Riggs (CEO)
Learn More about top insider investors at OncoCyte.